tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Aydin Huseynov, 51 are a BUY (79.69%), 13 are a HOLD (20.31%).
Analyst Aydin Huseynov, currently employed at LADENBURG, carries an average stock price target met ratio of 53.13% that have a potential upside of 83.9% achieved within 388 days. Previously, Aydin Huseynov worked at BENCHMARK.
Aydin Huseynov’s has documented 117 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on CMPX, Compass Therapeutics at 01-Jul-2026.
Analyst best performing recommendations are on NRBO (NEUROBO PHARMACEUTICALS).
The best stock recommendation documented was for NRBO (NEUROBO PHARMACEUTICALS) at 12/13/2022. The price target of $6 was fulfilled within 15 days with a profit of $7.2 (54.55%) receiving and performance score of 36.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$2
$1.97 (6566.67%)
$2
3 years 7 months 22 days ago
(15-Nov-2022)
3/4 (75%)
$-0.38 (-15.97%)
53
Buy
$8
$7.97 (26566.67%)
3 years 10 months 8 days ago
(29-Aug-2022)
0/1 (0%)
$4.17 (108.88%)
Buy
$140
$139.97 (466566.66%)
6 years 1 months 26 days ago
(11-May-2020)
0/2 (0%)
$3.2 (2.34%)
Buy
$340
$339.95 (679900.00%)
$240
9 years 3 months 8 days ago
(29-Mar-2017)
3/3 (100%)
$110.33 (71.65%)
163
Which stock is Aydin Huseynov is most bullish on?
Which stock is Aydin Huseynov is most reserved on?
What Year was the first public recommendation made by Aydin Huseynov?
